ask="7.79"
ask_size="3400"
average_daily_volume="61286"
bid="N/A"
bid_size="N/A"
book_value="-19.19"
change="+0.17"
change_from_200_day_moving_average="-0.12"
change_from_50_day_moving_average="-0.06"
change_from_52_week_high="-12.89"
change_From_52_week_low="1.04"
change_in_percent="+2.44%"
close="7.13"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-8.04"
ebitda="-18.31M"
eps_estimate_current_year="-1.07"
eps_estimate_next_quarter="0.00"
eps_estimate_next_year="-1.41"
ex_dividend_date="N/A"
float_shares="832000"
high="7.36"
high_52_weeks="20.02"
last_trade_date="2/9/2017"
last_trade_price="7.13"
last_trade_size="2530"
last_trade_time="4:00pm"
low="6.88"
low_52_weeks="6.09"
market_capitalization="17.38M"
moving_average_200_day="7.25"
moving_average_50_day="7.19"
name="KalVista Pharmaceuticals
Inc."
notes="N/A"
one_year_target_price="10.64"
open="6.98"
pe_ratio="N/A"
peg_ratio="0.00"
percent_change_from_200_day_moving_average="-1.60%"
percent_change_from_50_day_moving_average="-0.86%"
percent_change_from_52_week_high="-64.39%"
percent_change_from_52_week_low="+17.08%"
previous_close="6.96"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="N/A"
price_per_sales="9.57"
revenue="1.77M"
shares_outstanding="2437000"
short_ratio="1.08"
stock_exchange="NGM"
symbol="KALV"
volume="62093"
weeks_range_52="6.09 - 20.02"
